SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending due to positive three-year data on its Huntington's disease drug, AMT-130, exceeding expectations and potentially derisking accelerated FDA approval. Community discussions revolve around the halted stock, potential gap up, and possible links to CLPT, with some expressing concerns about a sharp sell-off. There is also active discussion about potential FDA approval.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron (MU) is trending following an "impressive" quarterly report that included results and guidance exceeding consensus estimates, with analysts subsequently raising price targets. The community is closely watching the stock's price action, debating whether the positive news was already priced in, while also considering the broader AI market and potential overbought conditions. Some traders are expressing frustration with perceived market manipulation and highlighting Micron's growth potential.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending due to its recent partnership with Red Lobster to implement AI-powered phone ordering across all locations, sparking excitement about potential future deals with larger chains like McDonald's. The community is also focused on the high short interest, anticipating a potential short squeeze, with some highlighting the broader implications of AI adoption across various industries. Bullish sentiment is fueled by the company's growth potential and innovative technology in the voice AI space.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as investors digest a Wells Fargo upgrade citing expected AWS sales acceleration and a hardware event on September 30th, though some community members express frustration with the stock's YTD performance compared to its peers. Discussions also include the FTC trial regarding Prime enrollments and closures of Amazon Fresh stores in the UK. Some traders are anticipating a potential dip while others are loading up for a Q4 rally.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is trending due to increased volume and community speculation about potential catalysts, including a possible buyout, upcoming presentations, and the Delaware court case. Community members are discussing insider buying, institutional ownership, and the potential impact of warrants expiring in January 2026. Some are expressing frustration with management and debating whether the stock is undervalued or a value trap.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" meme coin, $CAW.X, is trending due to its strong community and unique omnichain presence across Solana, BSC, Cronos, and Ethereum BASE. Community members highlight its fully circulated supply, organic growth, deflationary mechanisms and strategic partnerships as key factors driving interest. Some users are drawing comparisons to other surging coins and anticipate similar momentum for $CAW.X.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as shares surge following CEO Eddie Wu's plans to boost spending on AI and cloud infrastructure, with the company unveiling new AI products and a partnership with Nvidia. Cathie Wood's ARK Invest also made its first purchase of BABA since 2021, adding to the positive sentiment. The community is actively discussing the stock's valuation, AI potential, and potential impact from geopolitical factors.

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

ClearPoint Neuro Inc

ClearPoint Neuro ($CLPT) is trending as the community discusses its potential link to gene therapy companies like $QURE and recent FDA approvals in the neuro space, sparking interest in its role in delivering these therapies to the brain. Community members are also pointing to a recently published article and increased chatter from financial influencers as potential catalysts. Bullish sentiment is building due to strong technicals and the expectation of continued growth within the neuro indications sector.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending due to a recent downgrade from Jefferies, sparking debate about the company's valuation and future growth prospects. While some investors see the drop as a buying opportunity, citing previous positive analyst ratings and the company's fundamentals, others are concerned about unclear growth beyond 2026 and potential overvaluation. The community is actively discussing the impact of analyst ratings and the possibility of a coordinated effort to suppress the stock price.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

Uranium Energy Corp ($UEC) is trending amid discussions about its earnings, revenue potential from software licensing, and its position to capitalize on increased demand for nuclear energy to support data centers. Community members are actively debating the company's financial performance, insider buying activity, and the potential impact of rising uranium prices. Some traders are also evaluating technical indicators and potential entry points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Medical Stocks Lagging  atai Life Sciences (ATAI) This Year?

Here is how atai Life Sciences N.V. (ATAI) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.

atai Life Sciences (ATAI) Upgraded to Buy: Here's What You Should Know

atai Life Sciences (ATAI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Are Medical Stocks Lagging  Halozyme Therapeutics (HALO) This Year?

Here is how Halozyme Therapeutics (HALO) and atai Life Sciences N.V. (ATAI) have performed compared to their sector so far this year.

Here's Why atai Life Sciences (ATAI) Is a Great 'Buy the Bottom' Stock Now

atai Life Sciences (ATAI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

atai Life Sciences (ATAI) Upgraded to Strong Buy: Here's Why

atai Life Sciences (ATAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?

Here is how atai Life Sciences N.V. (ATAI) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.

5 Biotech Stocks with Highly Anticipated Pending Results

Others

Biotech M&A is heating up, making small-cap firms with breakthrough assets top acquisition targets and potential big winners for investors.

Are You Looking for a Top Momentum Pick? Why atai Life Sciences N.V. (ATAI) is a Great Choice

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

ATAI Life Sciences N.V.

$5,000

$6,000

$7,000

$8,000

What price will Ethereum hit in 2025? 
 
*Powered by Polymarket

ATAI
ATAI Life Sciences N.V.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ATAI News

ATAI ATAI Life Sciences N.V.